Höllviken, Sweden

Helene Dérand

USPTO Granted Patents = 19 

 

Average Co-Inventor Count = 5.0

ph-index = 12

Forward Citations = 357(Granted Patents)


Location History:

  • Hollviken, SE (2019)
  • Höllviken, SE (2016 - 2024)

Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Helene Dérand from Höllviken, SE

Introduction:

Helene Dérand is a prolific inventor hailing from Höllviken, SE, with an impressive total of 17 patents to his name. His innovative contributions to the field of pharmaceutical compositions have significantly impacted the industry.

Latest Patents:

Dérand's latest patents focus on pharmaceutical compositions containing poorly soluble drugs. Specifically, his inventions revolve around the development of stable, amorphous hybrid nanoparticles. These nanoparticles include essential components such as protein kinase inhibitors and polymeric stabilizers, which enhance the efficacy of pharmaceutical compositions used in therapy.

Career Highlights:

Throughout his career, Helene Dérand has been associated with renowned companies in the pharmaceutical sector. Some of the notable companies he has worked with include Xspray Microparticles AB and Xspray Pharma AB. His expertise and dedication to innovation have led to groundbreaking developments in drug delivery systems and pharmaceutical formulations.

Collaborations:

In his pursuit of excellence, Dérand has collaborated with esteemed professionals in the field. Among his coworkers are Magnus Brisander and Mustafa Demirbüker, who have contributed to the success of his projects through their expertise and teamwork.

Conclusion:

Helene Dérand's remarkable journey as an inventor underscores his commitment to advancing pharmaceutical technology. His inventive spirit and collaborative efforts continue to shape the landscape of drug development, paving the way for enhanced therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…